MHRA and Care Quality Commission (CQC) set out key principles to support their collaboration on improving public health.
Today we have set out how we will work more effectively with CQC in a new .
CQC is the independent regulator of health and social care services in England. They also monitor the use of the Mental Health Act 1983 and protect the interests of people whose rights are restricted under the Act.
We have worked closely with CQC on alert systems, medicines issues and online healthcare services. Our working relationship helps maintain an effective regulatory system for health and adult social care in England, while promoting patient safety and high quality care.
The new MoU sets out the framework to support our joint working relationship. We agree on how to share information, to carry out regulatory functions and to benefit the public. These principles underpin the MoU:
- addressing overlaps and gaps in the regulatory framework and responsibilities
- cooperating openly and transparently
- respecting each other’s independent status
- using resources and intelligence effectively and efficiently
Notes to Editor
- The Memorandum of Understanding was signed by Mr David Behan, Chief Executive, CQC and Dr Ian Hudson, Chief Executive, MHRA.
- MHRA is responsible for regulating all medicines and medical devices in the UK. All our work is underpinned by robust and fact-based judgments to ensure that the benefits justify any risks. MHRA is a centre of the Medicines and Healthcare products Regulatory Agency which also includes the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research Datalink (CPRD). The Agency is an executive agency of the Department of Health. www.mhra.gov.uk
Follow this news feed: HM Government